Mol Ther Methods Clin Dev
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Kang HR, Gjorgjieva M, Smith SN, Brooks ED, Chen Z, Burgess SM, Chandler RJ, Waskowicz LR, Grady KM, Li S, Mithieux G, Venditti CP, Rajas F, Koeberl DD
Glycogen storage disease type Ia (GSD Ia) is caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). GSD Ia complicat ...
Read More
Source: PubMed
J. Neurol. Neurosurg. Psychiatry 2019 Dec 18
Steno-occlusive cerebral arteriopathy in patients with glycogen storage disease type I.
Hong Y, Yuan Y, Shu S, Hou B, Dai Y, Ni J, Feng F, Qiu Z, Peng B
Read More
Source: PubMed
Mol Genet Metab Rep
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
Hijazi G, Pai N, Nagy LL, Herd S, Dickson J, Ram M, Inbar-Feigenberg M
Glycogen storage disease type I (GSDI) is caused by deficiency of the enzyme glucose-6-phosphatase or glucose-6-phosphate transporter. Mainstay of tre ...
Read More
Source: PubMed
Mol Ther Methods Clin Dev
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Kang HR, Gjorgjieva M, Smith SN, Brooks ED, Chen Z, Burgess SM, Chandler RJ, Waskowicz LR, Grady KM, Li S, Mithieux G, Venditti CP, Rajas F, Koeberl DD
Glycogen storage disease type Ia (GSD Ia) is caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). GSD Ia complicat ...
Read More
Source: PubMed
J. Neurol. Neurosurg. Psychiatry 2019 Dec 18
Steno-occlusive cerebral arteriopathy in patients with glycogen storage disease type I.
Hong Y, Yuan Y, Shu S, Hou B, Dai Y, Ni J, Feng F, Qiu Z, Peng B
Read More
Source: PubMed
Mol Genet Metab Rep
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
Hijazi G, Pai N, Nagy LL, Herd S, Dickson J, Ram M, Inbar-Feigenberg M
Glycogen storage disease type I (GSDI) is caused by deficiency of the enzyme glucose-6-phosphatase or glucose-6-phosphate transporter. Mainstay of tre ...
Read More
Source: PubMed
Mol Ther Methods Clin Dev
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Kang HR, Gjorgjieva M, Smith SN, Brooks ED, Chen Z, Burgess SM, Chandler RJ, Waskowicz LR, Grady KM, Li S, Mithieux G, Venditti CP, Rajas F, Koeberl DD
Glycogen storage disease type Ia (GSD Ia) is caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). GSD Ia complicat ...
Read More
Source: PubMed
J. Neurol. Neurosurg. Psychiatry 2019 Dec 18
Steno-occlusive cerebral arteriopathy in patients with glycogen storage disease type I.
Hong Y, Yuan Y, Shu S, Hou B, Dai Y, Ni J, Feng F, Qiu Z, Peng B
Read More
Source: PubMed
Mol Genet Metab Rep
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
Hijazi G, Pai N, Nagy LL, Herd S, Dickson J, Ram M, Inbar-Feigenberg M
Glycogen storage disease type I (GSDI) is caused by deficiency of the enzyme glucose-6-phosphatase or glucose-6-phosphate transporter. Mainstay of tre ...
Read More
Source: PubMed
Mol Ther Methods Clin Dev
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Kang HR, Gjorgjieva M, Smith SN, Brooks ED, Chen Z, Burgess SM, Chandler RJ, Waskowicz LR, Grady KM, Li S, Mithieux G, Venditti CP, Rajas F, Koeberl DD
Glycogen storage disease type Ia (GSD Ia) is caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). GSD Ia complicat ...
Read More
Source: PubMed
J. Neurol. Neurosurg. Psychiatry 2019 Dec 18
Steno-occlusive cerebral arteriopathy in patients with glycogen storage disease type I.
Hong Y, Yuan Y, Shu S, Hou B, Dai Y, Ni J, Feng F, Qiu Z, Peng B
Read More
Source: PubMed
Mol Genet Metab Rep
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
Hijazi G, Pai N, Nagy LL, Herd S, Dickson J, Ram M, Inbar-Feigenberg M
Glycogen storage disease type I (GSDI) is caused by deficiency of the enzyme glucose-6-phosphatase or glucose-6-phosphate transporter. Mainstay of tre ...
Read More
Source: PubMed
Mol Ther Methods Clin Dev
Pathogenesis of Hepatic Tumors following Gene Therapy in Murine and Canine Models of Glycogen Storage Disease.
Kang HR, Gjorgjieva M, Smith SN, Brooks ED, Chen Z, Burgess SM, Chandler RJ, Waskowicz LR, Grady KM, Li S, Mithieux G, Venditti CP, Rajas F, Koeberl DD
Glycogen storage disease type Ia (GSD Ia) is caused by mutations in the glucose-6-phosphatase (G6Pase) catalytic subunit gene (G6PC). GSD Ia complicat ...
Read More
Source: PubMed
J. Neurol. Neurosurg. Psychiatry 2019 Dec 18
Steno-occlusive cerebral arteriopathy in patients with glycogen storage disease type I.
Hong Y, Yuan Y, Shu S, Hou B, Dai Y, Ni J, Feng F, Qiu Z, Peng B
Read More
Source: PubMed
Mol Genet Metab Rep
Use of waxy maize heat modified starch in the treatment of children between 2 and 5?years with glycogen storage disease type I: A retrospective study.
Hijazi G, Pai N, Nagy LL, Herd S, Dickson J, Ram M, Inbar-Feigenberg M
Glycogen storage disease type I (GSDI) is caused by deficiency of the enzyme glucose-6-phosphatase or glucose-6-phosphate transporter. Mainstay of tre ...
Read More
Source: PubMed
